Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000229827 represents a pseudogene that bears similarity to portions of the inositol polyphosphate-5-phosphatase F (INPP5F) gene[4]. As a pseudogene, it contains defective copies of gene sequences that are presumed to be non-functional for protein production[2]. However, recent research has challenged the traditional view that pseudogenes are merely "junk DNA," revealing that many pseudogenes can have important biological functions despite their inability to code for proteins[5]. Pseudogenes can function through various RNA-based regulatory mechanisms, including processing into small interfering RNAs that may regulate their parent genes, acting as molecular sponges for microRNAs, or serving as decoys for transcription factors[5]. Some pseudogenes can influence chromatin organization and genomic architecture even without producing RNA transcripts, affecting gene expression through DNA-level interactions[5]. The parent gene family, inositol polyphosphate-5-phosphatases, plays crucial roles in cellular signaling by selectively dephosphorylating phosphoinositides, which are important membrane-bound signaling molecules involved in cell proliferation, survival, cytoskeletal reorganization, and vesicular trafficking[3][6]. These enzymes regulate various cellular processes including signal transduction, endocytosis, and actin polymerization[6]. While this specific pseudogene is not considered a therapeutic target, the growing understanding of pseudogene function suggests that copy number variations and other alterations in pseudogene sequences may contribute to disease susceptibility and could potentially be linked to complex diseases in the future[5].
Not applicable (not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of inositol polyphosphate-5-phosphatase F (ENSG00000229827).